OBJECTIVES: Physiological myocardial uptake of 18F-FDG during positron emission tomography can mask adjacent abnormal uptake in mediastinal malignancy and inflammatory cardiac diseases. Myocardial uptake is unpredictable and variable. This study evaluates the impact of a low-carbohydrate diet in reducing myocardial FDG uptake. METHOD: Patients attending for clinically indicated oncological FDG PET were asked to have an "Atkins-style" low-carbohydrate diet (less than 3 g) the day before examination and an overnight fast. A total of 120 patients following low-carbohydrate diet plus overnight fast were compared with 120 patients prepared by overnight fast alone. Patients having an Atkins-style diet also completed a diet compliance questionnaire. SUV(max) and SUV(mean) for myocardium, blood pool and liver were measured in both groups. RESULTS: Myocardial SUV(max) fell from 3.53 ± 2.91 in controls to 1.77 ± 0.91 in the diet-compliant group. 98 % of diet-compliant patients had a myocardial SUV(max) less than 3.6 compared with 67 % of controls. Liver and blood pool SUV(max) rose from 2.68 ± 0.49 and 1.82 ± 0.30 in the control group to 3.14 ± 0.57 and 2.06 ± 0.30. CONCLUSION: An Atkins-style diet the day before PET, together with an overnight fast, effectively suppresses myocardial FDG uptake. KEY POINTS : • Low-carbohydrate diet (LCD) the day before PET suppresses myocardial FDG uptake. • LCD before PET increases liver and blood pool SUV ( max ) and SUV ( mean ). • Suppression of myocardial uptake may improve PET imaging of thoracic disease. • Suppression of myocardial uptake may help imaging cardiac inflammatory disease with PET.
OBJECTIVES: Physiological myocardial uptake of 18F-FDG during positron emission tomography can mask adjacent abnormal uptake in mediastinal malignancy and inflammatory cardiac diseases. Myocardial uptake is unpredictable and variable. This study evaluates the impact of a low-carbohydrate diet in reducing myocardial FDG uptake. METHOD:Patients attending for clinically indicated oncological FDG PET were asked to have an "Atkins-style" low-carbohydrate diet (less than 3 g) the day before examination and an overnight fast. A total of 120 patients following low-carbohydrate diet plus overnight fast were compared with 120 patients prepared by overnight fast alone. Patients having an Atkins-style diet also completed a diet compliance questionnaire. SUV(max) and SUV(mean) for myocardium, blood pool and liver were measured in both groups. RESULTS:Myocardial SUV(max) fell from 3.53 ± 2.91 in controls to 1.77 ± 0.91 in the diet-compliant group. 98 % of diet-compliant patients had a myocardial SUV(max) less than 3.6 compared with 67 % of controls. Liver and blood pool SUV(max) rose from 2.68 ± 0.49 and 1.82 ± 0.30 in the control group to 3.14 ± 0.57 and 2.06 ± 0.30. CONCLUSION: An Atkins-style diet the day before PET, together with an overnight fast, effectively suppresses myocardial FDG uptake. KEY POINTS : • Low-carbohydrate diet (LCD) the day before PET suppresses myocardial FDG uptake. • LCD before PET increases liver and blood pool SUV ( max ) and SUV ( mean ). • Suppression of myocardial uptake may improve PET imaging of thoracic disease. • Suppression of myocardial uptake may help imaging cardiac inflammatory disease with PET.
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Michael T Osborne; Edward A Hulten; Venkatesh L Murthy; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Marcelo F DiCarli; Ron Blankstein Journal: J Nucl Cardiol Date: 2016-06-08 Impact factor: 5.952
Authors: Kate Hanneman; Christian Houbois; Alice Schoffel; Dakota Gustafson; Robert M Iwanochko; Bernd J Wintersperger; Rosanna Chan; Jason E Fish; Kathryn L Howe; Paaladinesh Thavendiranathan Journal: JAMA Cardiol Date: 2022-03-01 Impact factor: 14.676
Authors: Brett W Sperry; Timothy M Bateman; Esma A Akin; Paco E Bravo; Wengen Chen; Vasken Dilsizian; Fabien Hyafil; Yiu Ming Khor; Robert J H Miller; Riemer H J A Slart; Piotr Slomka; Hein Verberne; Edward J Miller; Chi Liu Journal: J Nucl Cardiol Date: 2022-07-21 Impact factor: 3.872
Authors: Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause Journal: Eur J Nucl Med Mol Imaging Date: 2014-12-02 Impact factor: 9.236